Quantification of percent MC-1+ immunoreactive area in the respective retinas indicated significant and modest 2.0-fold and 1.8-fold increases in MCI and AD patients compared to NC controls, respectively (Fig. 1g). The gene discussed is ATP7A; the disease is Alzheimer disease.